Related Experiment Videos
[Lung transplantation. Possibilities and limitations].
J Gottlieb1, T Welte, M M Höper
1Abteilung Pneumologie, Medizinische Hochschule Hannover. gottlieb.jens@mh-hannover.de
Der Internist
|October 14, 2004
Summary
Lung transplantation offers survival benefits for end-stage lung diseases like cystic fibrosis, improving life expectancy. However, challenges like organ rejection and infections persist, impacting long-term outcomes.
Area of Science:
- Pulmonology and Thoracic Surgery
- Transplant Medicine
Context:
- Lung transplantation is a critical treatment for end-stage pulmonary diseases.
- European studies indicate survival advantages for specific conditions including cystic fibrosis, pulmonary fibrosis, and emphysema.
- Surgical advancements have recently decreased early mortality rates.
Purpose:
- To review the current status, benefits, and challenges of lung transplantation.
- To highlight improvements in survival and quality of life post-transplant.
- To identify persistent complications and long-term risks.
Summary:
- Lung transplantation improves survival and quality of life for patients with end-stage lung diseases.
- While early mortality has decreased, long-term life expectancy remains lower than other solid organ transplants.
- Frequent complications include organ rejection, infections, airway issues, and a higher incidence of malignancies.
- Average 5-year survival rates are approximately 60%.
Impact:
- Provides a comprehensive overview of lung transplantation outcomes.
- Informs clinical decision-making and patient counseling regarding lung transplant risks and benefits.
- Highlights areas for future research to improve long-term graft survival and patient well-being.